Cargando…
The ascent of immune checkpoint inhibitors: is the understudy ready for a leading role?
Autores principales: | Cummings, Amy L., Garon, Edward B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785166/ https://www.ncbi.nlm.nih.gov/pubmed/29372100 http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0090 |
Ejemplares similares
-
Management of arrhythmias in underserved and understudied patient populations
por: Poole, Jeanne E.
Publicado: (2022) -
Immune understudies combat lupus
por: Leslie, Mitch
Publicado: (2009) -
Rising to the challenge: designing, implementing and reporting exercise oncology trials in understudied populations
por: Lahart, Ian M., et al.
Publicado: (2020) -
The ascent of science
por: Silver, Brian L
Publicado: (1998) -
Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy
por: Young, M. Rita I.
Publicado: (2017)